Eurobio Scientific SA (ALERS) — Cash Flow-to-Debt Ratio
Eurobio Scientific SA (ALERS) has a Cash Flow-to-Debt Ratio of 0.07x as of June 2025, meaning its operating cash flow of €5.36 Million could theoretically repay 0% of its total liabilities (€78.26 Million) in one year. See Eurobio Scientific SA financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Eurobio Scientific SA Cash Flow-to-Debt Ratio (2007–2024)
Historical debt coverage capacity for Eurobio Scientific SA across 18 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Eurobio Scientific SA.
Annual Cash Flow-to-Debt Ratio for Eurobio Scientific SA (2007–2024)
Year-by-year debt coverage analysis for Eurobio Scientific SA. Check Eurobio Scientific SA cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.21x | €16.70 Million | €78.31 Million | ▲ +12.5% |
| 2023 | 0.19x | €26.77 Million | €141.16 Million | ▼ -30.6% |
| 2022 | 0.27x | €43.07 Million | €157.75 Million | ▼ -79.7% |
| 2021 | 1.35x | €65.92 Million | €49.00 Million | ▲ +57.8% |
| 2020 | 0.85x | €54.93 Million | €64.45 Million | ▲ +659.0% |
| 2019 | 0.11x | €4.99 Million | €44.44 Million | ▲ +964.7% |
| 2018 | -0.01x | €-523.00K | €40.27 Million | ▼ -120.9% |
| 2017 | 0.06x | €2.48 Million | €39.88 Million | ▲ +136.8% |
| 2016 | -0.17x | €-3.32 Million | €19.66 Million | ▲ +14.4% |
| 2015 | -0.20x | €-2.44 Million | €12.40 Million | ▲ +26.9% |
| 2014 | -0.27x | €-3.38 Million | €12.55 Million | ▲ +29.3% |
| 2013 | -0.38x | €-4.90 Million | €12.85 Million | ▼ -20.0% |
| 2012 | -0.32x | €-4.45 Million | €13.99 Million | ▲ +78.7% |
| 2011 | -1.49x | €-6.02 Million | €4.04 Million | ▼ -210.4% |
| 2010 | -0.48x | €-5.80 Million | €12.07 Million | ▲ +20.5% |
| 2009 | -0.60x | €-6.71 Million | €11.09 Million | ▼ -26.4% |
| 2008 | -0.48x | €-9.62 Million | €20.11 Million | ▼ -89.3% |
| 2007 | -0.25x | €-4.93 Million | €19.52 Million | — |